Overview

Under the agreement of this take-private transaction worth C$9 billion, Boralex will continue to operate as an independent private company following closing.

Our Outlook Series 2026 provides forward‑looking analysis of the most important legal, regulatory, and market developments affecting Canadian organizations.

David focuses his practice on the resolution of intellectual property disputes (patents, trade-marks and copyright) and related commercial issues, by providing strategic advice and litigation services to a variety of clients.

With regard to patent law and patent litigation in Canada, David frequently represents innovative life sciences and pharmaceutical industry clients in patent infringement actions, PM(NOC) proceedings and Section 8 damages cases. He also provides strategic regulatory and litigation advice on medicines (Notice of Compliance), natural health products (Natural Health Product Licence) and Patented Medicines Prices Review Board issues.

David represents clients before the Federal Court, the Federal Court of Appeal and the Ontario Court.

Practice Areas

• Civil Litigation
• Intellectual Property

Bar Information

Called to the bar: 2003 (ON)